Blucora, Inc. (AVTA) Tops Q2 EPS by 21c

Blucora, Inc. (NASDAQ: AVTA) reported Q2 EPS of $0.36, $0.21 better than the analyst estimate of $0.15. Revenue for the quarter came in at $186.3 million versus the consensus estimate of $188.12 million.

For earnings history and earnings-related data on Blucora, Inc. (AVTA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c